Epigenetics in drug development and diagnostics - digital talks

Watch the talks and panel discussion on demand from our final session of 'Epigenetics - From Bench to Clinic'


Summary

Hear leaders in the field present their latest research on epigenetics in drug development and diagnostics. The short web-based meeting is intended to highlight exciting developments in the field and continue the sharing of knowledge within the epigenetics community.


Webinar objectives

Gain a greater understanding of  targeting two epigenetic erasers: Dual inhibition of HDAC6 and LSD1

Demonstrate an increased  knowledge of cell free circulating nucleosomes

Understand  the emerging  role that targeting EZH2 has in the treatment of Follicular Lymphoma 
  • Gain a greater understanding of  targeting two epigenetic erasers: Dual inhibition of HDAC6 and LSD1 
  • Demonstrate an increased  knowledge of cell free circulating nucleosomes
  • Understand  the emerging  role that targeting EZH2 has in the treatment of Follicular Lymphoma 

​

​​Abcam is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.  Interested in receiving P.A.C.E credit for this educational session? Request credit here!

​​

Speakers

  • A. Ganesan, University of East Anglia
    • Targeting two epigenetic erasers: Dual inhibition of HDAC6 and LSD1
  • Mark Eccleston, Volition
    • Nu.Q-Capture - Isolation and profiling of tumor derived, cell free circulating nucleosomes
  • Neil Michaud, Epizyme
    • Targeting EZH2 to Treat Follicular Lymphoma: The Tazverik Story​

Moderator

​​

Contact

Have a question? Please contact the Abcam Events Team.